• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Threshold Pharmaceuticals Inc

+ Add to Watchlist

THLD:US

4.0432 USD 0.4268 9.55%

As of 12:13:15 ET on 09/22/2014.

Snapshot for Threshold Pharmaceuticals Inc (THLD)

Open: 4.3600 Day's Range: 3.9401 - 4.4700 Volume: 1,987,162
Previous Close: 4.4700 52wk Range: 3.5100 - 5.9300 1-Yr Rtn: -12.07%

Stock Chart for THLD

No chart data available.
  • THLD:US 4.0450
  • 1D
  • 1M
  • 1Y
4.4700
Interactive THLD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THLD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3700
Est. EPS (USD) (12/2014) -0.4540
Est. PEG Ratio -
Market Cap (M USD) 246.96
Shares Outstanding (M) 59.37
30 Day Average Volume 825,062
Price/Book (mrq) -
Price/Sale (ttm) 17.3867
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THLD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THLD

Threshold Pharmaceuticals Inc. is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells.

Harold E Selick "Barry"Chief Executive OfficerTillman PearceChief Medical Officer
Robert L Simon "Bob"Senior VP:Regulatory AffairsJoel A FernandesVP:Finance/Controller
More Company Profile & Key Executives for THLD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil